Zerion Pharma A/S
- Biotech or pharma, therapeutic R&D
ZERION is a pharmaceutical development company focused on improving the bioavailability of oral drug products by increasing their solubility. Improved drug solubility results in significant patient benefits in the form of lower drug doses, fewer side effects and reduction in the number of tablets to be taken. ZERION has multiple research and commercial partnerships with pharma/biotech companies aimed at improving existing marketed medical products as well as completely new drugs applying ZERION’s Dispersome® technology. Contrary to current available synthetic chemistry- based solutions, the Dispersome® technology platform is based on using the renewable food protein beta-lactoglobulin (BLG) to enhance drug solubility and bioavailability.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}